+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cyclobenzaprine"

Muscle Relaxant Drugs Market Report 2025 - Product Thumbnail Image

Muscle Relaxant Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Fibromyalgia - Pipeline Insight, 2025 - Product Thumbnail Image

Fibromyalgia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Pain Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Acute Pain Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Pain Management Drugs Market Overview, 2025-2030 - Product Thumbnail Image

Pain Management Drugs Market Overview, 2025-2030

  • Report
  • November 2025
  • 138 Pages
  • Global
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Cyclobenzaprine is an analgesic drug used to treat muscle spasms and pain. It is a centrally acting skeletal muscle relaxant, and is commonly used in combination with physical therapy and rest for the relief of muscle spasms associated with acute, painful musculoskeletal conditions. It is available in both immediate-release and extended-release formulations. Cyclobenzaprine is generally well-tolerated, with the most common side effects being drowsiness, dizziness, and dry mouth. Cyclobenzaprine is available in generic form, as well as under the brand names Flexeril and Amrix. It is available in tablet, capsule, and liquid form. It is also available in combination with other analgesics, such as ibuprofen and acetaminophen. Cyclobenzaprine is a popular choice for the treatment of muscle spasms and pain, due to its effectiveness and low cost. It is widely available, and is often prescribed in combination with other analgesics. Some companies in the Cyclobenzaprine market include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more